The collaboration marks a turning point in AI-driven drug design and trial forecasting, de-risking the drug development ...

The startup has partnered with Eli Lilly and enjoys the backing of some of Silicon Valley's most influential VCs.

Real-time ¹⁹F NMR enables faster, more efficient pharmaceutical synthesis by improving reaction monitoring, scalability, and ...

PharmTech spoke with Dr. Asma Patel, VP Global Commercial and Scientific Consulting–Drug Product, to find out how the growth ...

For decades, discovery has relied on "brute force" mass-screening – testing thousands of random compounds hoping one will ...

Functional packaging materials are increasingly designed to actively protect drug products, integrating moisture and impurity ...

The future of clinical research depends on people just as much as strong systems and processes. Learn what makes great ...

Attorney General Pam Bondi has missed a congressionally mandated deadline to issue guidelines for easing barriers to research ...

An FDA draft guidance nixing the requirement for biosimilar manufacturers to conduct comparative efficacy studies may prove ...

Scientists have developed a new treatment strategy that could one day save the lives of children affected by aggressive brain ...

A CDMO championing a commitment to patients may sound like lip service or branding, but truly patient-centric CDMOs offer ...

The company applies AI to optimize molecules across discovery and production with aims to contribute to the rebuilding of U.S.-based drug innovation and manufacturing.